Alectinib compared with chemotherapy in previously treated patients with ALK-positive NSCLC (ALUR)

Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and Crizotinib

Cancer
Lung Cancer
Non-Small Cell Lung Cancer (NSCLC)

Results
Download
Print

Study results

RO_MO29750_final-results-summary_Mar2022_English.pdf (PDF, 0.3 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

Alectinib compared with chemotherapy in previously treated patients with ALK-positive NSCLC (ALUR)

Study results

RO_MO29750_final-results-summary_Mar2022_English.pdf (PDF, 0.3 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

Alectinib compared with chemotherapy in previously treated patients with ALK-positive NSCLC (ALUR)

For the latest version of this information please go to www.forpatients.roche.com